Cathy Pareto & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Sell
4,133
-1,316
-24% -$86.5K 0.16% 86
2026
Q1
$387K Sell
5,449
-577
-10% -$45.5K 0.26% 64
2025
Q4
$494K Sell
6,026
-744
-11% -$58K 0.34% 53
2025
Q3
$508K Sell
6,770
-748
-10% -$55.8K 0.38% 50
2025
Q2
$557K Sell
7,518
-512
-6% -$35.6K 0.46% 45
2025
Q1
$648K Sell
8,030
-545
-6% -$46.8K 0.57% 38
2024
Q4
$670K Buy
+8,575
New +$729K 0.62% 38

Other funds holding GEHC

Cathy Pareto & Associates's GEHC Position: Q2 2026 in Review

Cathy Pareto & Associates reduced its GE HealthCare (GEHC) stake by 24% in Q2 2026, selling an estimated $86.5K and leaving 4,133 shares worth $265K. The position accounts for 0.16% of the portfolio, ranked #86.

Cathy Pareto & Associates first reported a position in GEHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $670K in Q4 2024. 262 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cathy Pareto & Associates held 4,133 shares of GE HealthCare worth $265K as of Q2 2026.
  • Cathy Pareto & Associates sold 1,316 GE HealthCare shares in Q2 2026, an estimated $86.5K.
  • GE HealthCare made up 0.16% of Cathy Pareto & Associates's portfolio in Q2 2026, its #86 holding.
  • Cathy Pareto & Associates first reported a position in GE HealthCare in Q4 2024 and has held it in 7 quarters since.
  • Cathy Pareto & Associates's GE HealthCare position peaked at $670K in Q4 2024.
  • 262 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cathy Pareto & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.